Defective Drug Lawsuits - Baycol, Bextra, Duract, Fen-Phen

                                                                                         

Defective drugs have caused a number of injuries and serious illness over time. This is a sampling of just some of these lawsuits.

Baycol®: Originally approved by the FDA in 1997 for use as an anti-cholesterol drug, Baycol® was removed from the market in 2001 due to the serious dangers it presented to patients. Baycol® has been found to cause rhabdomyolysis, a condition that leads to a breakdown of muscle cells and allows its contents to be released into the blood. Rhabdomyolysis can result in pain and muscle weakness. As the kidneys fail, it can also cause paralysis and wrongful death.

Bextra®: Also known as valdecoxib, Bextra® is used to abate the pain, tenderness, swelling, and stiffness resulting from arthritis, and for the treatment of menstrual cramps. Bextra® is part of a non-steroidal anti-inflammatory class of drugs that includes Vioxx and Celebrex, called COX-2 inhibitors. These drugs were intended to prevent the gastrointestinal problems caused by other arthritis medications. However, there is evidence that other COX-2 inhibitors are dangerous for the heart, leading to serious concerns about the safety of Bextra®. In 2002, reports of serious or life-threatening hypersensitivity and skin reactions in Bextra® users prompted the FDA to issue a safety alert and changes to the product labeling, warning patients of such side effects.

Duract™: Previously used as a short-term pain relief medication, Duract™ was recalled in 1998 after serious liver damage was found to be associated with the drug. Because of the dangers that Duract™ could pose to the liver, the drug was approved for use, but not to exceed 10 days. However, some patients and doctors did not follow proper instructions for Duract™ use, leading to cases of severe liver damage, including liver failure and wrongful death .

Fen-Phen: Before the drug was recalled by the FDA due to dangers, Fen-Phen was used by millions of Americans as a weight loss drug. In 1997, the drug was with drawn from the market following evidence that Fen-Phen use was linked to incidences of heart valve defects and primary pulmonary hypertension.

About the author:
To learn more about your legal entitlements, it is important to speak with a skilled Sacramento car accident attorneys, Stockton and Modesto product liability attorneys, and skilled Sacramento personal injury attorneys for more information.

Article Source: http://www.Free-Articles-Zone.com